Suspected adverse reactions, 2009

Abstract

Twenty‐five fewer reports to the UK Suspected Adverse Reaction Surveillance Scheme (SARSS) in 2009 compared with 2008 Renal insufficiency reported in cats after off‐label use of meloxicam Increase in reports of suspected lack of efficacy to products containing triclabendazole Significant decrease in environmental incidents attributable to veterinary medicines These are some of the results from the SARSS in 2009, as discussed by Fabia Dyer and colleagues from the Veterinary Medicines Directorate